Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lee Nisley Newcomer Insider Profile
4 Followers
Lee Nisley Newcomer, Director at Myriad Genetics, holds 82.34K shares in Myriad Genetics (Ticker: MYGN), holds ― shares in Coherus Biosciences (Ticker: CHRS).
Lee Nisley Newcomer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lee Nisley Newcomer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lee Nisley Newcomer
Lee Nisley Newcomer's Trading History
Myriad Genetics
Jun 07, 2024
Director
Uninformative Buy
―
$2.14M
Coherus Biosciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Lee Nisley Newcomer's performance on stock
You May Also Like
Lee Nisley Newcomer insider profile FAQ
What is the percentage of profitable transactions made by Lee Nisley Newcomer?
The percentage of profitable transactions made by Lee Nisley Newcomer is ―.
What is the average return per transaction made by Lee Nisley Newcomer?
The average return per transaction made by Lee Nisley Newcomer is ―.
What stocks does Lee Nisley Newcomer hold?
Lee Nisley Newcomer holds: MYGN, CHRS stocks.
What was Lee Nisley Newcomer’s latest transaction?
Lee Nisley Newcomer latest transaction was an Uninformative Buy of ―.
What was Lee Nisley Newcomer's most profitable transaction?
Lee Nisley Newcomer’s most profitable transaction was an Informative Sell of MYGN stock on May 15, 2024. The return on the trade was -5.30%.
What is Lee Nisley Newcomer's role in Myriad Genetics?
Lee Nisley Newcomer's role in Myriad Genetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.